Skip to main content

bioMerieux Value Stock - Dividend - Research Selection

bioMérieux S.A

ISIN: FR0013280286, WKN: A2DXZH

Market price date: 21.01.2022
Market price: 101,70 EUR

bioMérieux S.A Fundamental data and company key figures of the share

Annual reports in EUR
Key figures 13-09-2021
Cash flow
Net operating cash flow 582.800.000
Capital Expenditures -277.500.000
Free cash flow 305.300.000
Balance sheet
Total Equity 2.481.300.000
Liabilities & Shareholders equity 3.927.800.000
Income statement
Net income 404.400.000
Eps (diluted) 3,418
Diluted shares outstanding 118.302.000
Net sales/revenue

Fundamental ratios calculated on: 21-01-2022

Key figures 21-01-2022
Cash flow
P/C 20,64
P/FC 39,41
Balance sheet
Income statement
Div. Yield0,61%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization14.592.253.952,00 USD
IndicesSTOXX EUROPE 600,MSCI World Index
SectorsHealth Care Services
Raw Data SourceIFRS in Millionen EUR
Stock Split2017-09-20,3.000000/1.000000

Description of the company

bioMérieux S.A. develops and produces in vitro diagnostic solutions for private and hospital laboratories for the diagnosis of infectious diseases. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,